PMC9034893_01
Female patient aged 55 years old presented with right upper temporal BRVO, the CMT was 295 um, the BCVA was 1.2 by log MAR (A), the patient received single combined intravitreal injection of ranibizumab (0.5mg) and suprachoroidal injection of TA (4 mg), the CMT declined to 195 um and BCVA improved to 0.3 after 1 month (B), after 3 months of the first injection, the CMT was 187 um and BCVA was 0.2 (C), after 6 months of the first injection, the CMT was 192 um and BCVA was 0.2 (D), after 12 months of the first injection, the CMT was 185 um and BCVA was 0.2 (E).
OPTH-16-1139-g0004.jpg
PMC9034893_01_OPTH-16-1139-g0004.jpg
f0004
PMC9034893_02
Male patient aged 48 years old presented with right upper temporal BRVO, the CMT was 393 um, the BCVA was 1.3 by log MAR (A), the patient received 3 consecutive intravitreal injections of ranibizumab (0.5 mg), the CMT declined to 211 um and BCVA improved to 0.4 after 3 months (B), after 6 months of the first injection, recurrent ME occurred with CMT 332 um and the BCVA declined to 1.2 by log MAR (C), the patient received two additional injections of ranibizumab, after 12 months of the first injection, the CMT was 194 um and BCVA improved to 0.3 (D).
OPTH-16-1139-g0005.jpg
PMC9034893_02_OPTH-16-1139-g0005.jpg
f0005